HCC

This study is testing if a new pre-surgery treatment can better control liver cancer and prevent it from returning. It will compare two approaches in 110 patients with operable liver cancer. One group gets a combination of immunotherapy (sintilimab) and targeted radiation before …

This study is testing if combining two standard treatments works better for inoperable liver cancer. Patients will receive immunotherapy drugs plus a localized procedure called TACE that blocks blood flow to the tumor. Researchers hope this one-two punch will shrink tumors more e…

This study is testing a new combination treatment for people with advanced liver cancer (hepatocellular carcinoma) who also have high blood pressure in their liver (portal hypertension) due to cirrhosis. The treatment combines a minimally invasive procedure (TACE) with three drug…

This study aims to find the best combination treatment for advanced liver cancer that cannot be removed by surgery. It will compare two different local drug delivery methods (TACE and HAIC), each combined with two other cancer drugs, in about 364 patients. The main goal is to see…

This study aims to see if an artificial intelligence (AI) model can better identify which liver cancer patients need immunotherapy after surgery to prevent the cancer from coming back. It will follow 300 patients who have had their liver tumors surgically removed. The AI will ana…

This study is testing a blood test that looks for tiny amounts of leftover cancer DNA after liver cancer surgery. Researchers want to see if this test can better predict which patients' cancer is likely to return. The study will also help identify which patients might benefit mos…

This study is testing a new type of medical scan to see if it can better detect and locate liver cancer tumors. It will involve 6 people who have or are strongly suspected to have liver cancer. The main goal is to see how a special imaging agent moves through the body, if it's sa…